Dr. Reddy's gains as it working on development of new treatment options for COVID-19 patients

24 May 2021 Evaluate

Dr. Reddys Laboratories is currently trading at Rs. 5261.00, up by 44.25 points or 0.85% from its previous closing of Rs. 5216.75 on the BSE.

The scrip opened at Rs. 5225.00 and has touched a high and low of Rs. 5279.50 and Rs. 5225.00 respectively. So far 15929 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 5514.65 on 21-Sep-2020 and a 52 week low of Rs. 3815.00 on 22-May-2020.

Last one week high and low of the scrip stood at Rs. 5305.00 and Rs. 5143.50 respectively. The current market cap of the company is Rs. 87718.08 crore.

The promoters holding in the company stood at 26.74%, while Institutions and Non-Institutions held 43.93% and 17.06% respectively.

Dr Reddy's Laboratories is working on the development of new treatment options for COVID-19 patients which it aims to launch over the next few months while ensuring uninterrupted supplies of its existing range of products for the infectious disease in the market. The company has already launched Sputnik V vaccine while partnering various organisations, including the Defence Research and Development Organisation. 

Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.

Dr. Reddys Lab Share Price

1246.25 -20.90 (-1.65%)
09-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1776.20
Dr. Reddys Lab 1246.25
Cipla 1490.70
Zydus Lifesciences 919.90
Lupin 2052.05
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×